logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

School admissions: closing the gap?

23 July 2014

Press reports have highlighted government proposals to amend the School Admissions Code and allow all schools to give greater priority to pupils who are eligible for the Pupil Premium (usually pupils who are eligible for free school meals). Currently, only academies and free schools have this freedom. The report indicates that such a move could squeeze out middle class parents who may find it more difficult to obtain a place at a good school.

The government proposals should provide a level playing field for all schools to be able to prioritise pupil premium pupils. There is no obligation to do so and is very much about schools making decisions which benefit their local community. If the changes are made to the Admissions Code, it will benefit schools by potentially providing access to greater funds but also allow greater engagement with disadvantaged families to ensure that the gap between the 'haves' and 'have-nots' is closed.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up